Artivion Valuation Multiples

Artivion Overview

About Artivion

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Founded

1984

HQ

Employees

1.8K

Website

artivion.com

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $457M

EBITDA: $95M

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

Artivion Financials

Artivion reported last 12-month revenue of $457M and EBITDA of $95M.

In the same LTM period, Artivion generated $296M in gross profit, $95M in EBITDA, and $13M in net income.

Artivion P&L

In the most recent fiscal year, Artivion reported revenue of $441M and EBITDA of $90M.

Artivion expects next 12-month revenue of XXX and NTM EBITDA of XXX

Artivion Stock Performance

Artivion has current market cap of $2B, and enterprise value of $2B.

Artivion's stock price is $37.72.

Artivion Valuation Multiples

Artivion trades at 4.4x EV/Revenue multiple, and 21.4x EV/EBITDA.

Artivion Financial Valuation Multiples

As of April 20, 2026, Artivion has market cap of $2B and EV of $2B.

Equity research analysts estimate Artivion's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Artivion has a P/E ratio of 145.7x.

Artivion Margins & Growth Rates

Artivion's revenue in the last 12 month grew by 12%.

Artivion's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Artivion's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Artivion's rule of X is 51% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Artivion Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Artivion M&A Activity

Artivion acquired XXX companies to date.

Last acquisition by Artivion was on XXXXXXXX, XXXXX. Artivion acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Artivion Investment Activity

Artivion invested in XXX companies to date.

Artivion made its latest investment on XXXXXXXX, XXXXX. Artivion invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).